Greenberg Traurig Continues to Enhance Life Sciences and Medical Technology Capabilities

Share Article

Greenberg Traurig Continues to Enhance Life Sciences and Medical Technology Capabilities

International law firm Greenberg Traurig, LLP has enhanced its life sciences law capabilities with the appointment of existing shareholders David J. Dykeman and David C. Peck as co-chairs of the global Life Sciences and Medical Technology Group. The group is comprised of attorneys from across practice and industry groups who serve the life sciences, medical technology, and healthcare industries, including litigation, intellectual property, technology, corporate transactions, finance, government regulation, global healthcare privacy, real estate, and capital markets.

“The life sciences industry faces new opportunities and challenges in the era of healthcare reform,” said Richard A. Rosenbaum, Greenberg Traurig’s Chief Executive Officer. “The focus on improving patient outcomes and delivering coordinated, quality medical care, while facing increased regulatory and pricing pressures, means life sciences and medical technology companies must develop new business and legal strategies in order to maintain a competitive edge. The co-chairs come from different sectors of the healthcare legal market, but they both bring a wealth of passion and experience to this dynamic market and as practice co-chairs, they will deepen our ability to assist clients at the forefront of life science and medtech innovation.”

Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through product marketing.

Dykeman is a patent attorney in the firm’s Intellectual Property & Technology Practice Group who focuses his practice on securing strategic worldwide intellectual property protection and related business strategy for high-tech clients, with particular expertise in life sciences, medical devices, biotechnology and healthcare IT. Dykeman is the author of over 35 articles, has been honored as one of “40 Medtech Innovators Under 40” by MD+DI magazine, and was named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine.

Peck is a shareholder in the firm’s Corporate & Securities and Private Equity Practice Groups and works with emerging growth companies, established entities and private equity firms in executing their strategic plans in the areas of healthcare IT, life sciences, and healthcare services. He assists companies beginning with corporate formation, obtaining and structuring equity and debt financing, mergers and acquisitions, as well as the integration of acquired operations, undertaking initial public offerings, and continuing through to liquidity and exit strategies. Peck has been listed in Best Lawyers in America in Health Care Law since 2006.

About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, full-service law firm with approximately 1750 attorneys serving clients from 36 offices in the United States, Latin America, Europe, the Middle East and Asia. In the U.S., the firm has more offices than any other among the Top 10 on The National Law Journal's 2012 NLJ 250. For additional information, please visit http://www.gtlaw.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Nicole Glinski
Greenberg Traurig
+ 1 212 801 6747
Email >
Visit website